The availability of high affinity antibodies to the human TSH receptor (TSHR) 
INTRODUCTION
The growth and differentiated function of the thyroid are controlled by thyrotrophin (TSH) which, on binding to its receptor, activates primarily the adenylyl cyclase-cyclic AMP (cAMP) cascade . The TSH receptor (TSHR), like those of the other glycoprotein hormones, luteinizing hormone (LH) and follicle-stimulating hormone, is a G proteincoupled receptor which is predicted to span the cell membrane seven times (Libert et al. 1991è ). The TSHR thus has three extracellular loops and an extensive extracellular amino terminus which to¬ gether constitute the ligand-binding site. The membrane-spanning domains with the three intracellular loops plus the carboxyl terminus are responsible for G protein coupling and signal transduction Vassart et al. 1991) . In addition to its natural ligand, the TSHR is the target of thyroid-stimulating autoantibodies (TSAbs) (Manley et al. 1982) , which result in the hyperthyroidism characteristic of Graves' disease (Rees Smith et al. 1988 ), or autoantibodies which may bind and interfere with TSH binding, TSH-blocking antibodies (TBAbs), resulting in hypothyroidism in some cases of idiopathic myxoedema (Orgiazzi et al. 1976; Matsuura et al. 1993 ).
Since its cloning, many diverse strategies have been employed to try to define the binding sites of TSH/TSAbs/TBAbs and to elucidate how these large ligands do or do not affect signal transduction (Nagayama & Rapoport, 1992; Baker, 1993) . The use of LHR/TSHR chimeras and screening a TSHR epitope library (Libert et al. 1991a ) have revealed that TSH-/TSAb-/TBAb-binding sites are conformational and are thus composed of discon¬ tinuous segments throughout the extracellular domains (ECDs) . These findings are difficult to reconcile with studies making use of synthetic peptides of the receptor, either to produce antibod¬ ies which have biological activity or to measure directly the binding of autoantibodies (Ohmori et al. 1991; Sakata et al. 1992) . Another approach has been to produce full-length or truncated receptors in eukaryotic or prokaryotic expression systems; this has resulted in the establishment of binding (Costagliola et al. 1992 ) and bioassays ) for TSAbs/TBAbs, and the demonstration that high affinity binding of TSH requires all of the extracellular part of the receptor, unlike autoanti¬ bodies whose binding seems not to require the loops (Harfst et al. 1992) .
Some previous studies have produced monoclonal antibodies to the TSHR (Costagliola et (Saiki et al. 1988 ). The fragment was introduced into the polylinker of vector pMAL-cRl (Maina et al. 1988) (Bradford, 1976 (Laemmli, 1970) Purified plasma membranes were obtained by discontinuous sucrose gradient centrifugation. The 40 000 g membrane pellet was resuspended in 3-5 ml 3 mM Tris-Cl, pH 7-4, 1 mM EGTA (buffer B) enriched with 50% (w/w) sucrose (density= 1-23 g/ml) to obtain a concentration of 2 mg protein/ml. This solution was placed in 13-5 ml tubes and overlaid by sucrose solutions of 41% (2-2 ml; density=L18 g/ml), 37% (3-2 ml; density1 16 g/ml) and 26% (2-9 ml; density=l-10 g/ml) (Carayon et al. 1979 (Bradford, 1976 
RESULTS

Protein expression
An 89 kDa species, representing the major protein of the total bacterial lysate, appeared on Coomassie blue-stained SDS-polyacrylamide gels for E. coli transformed with pMAL-cRl-ECD and induced with 50 pM IPTG (Fig. 1, lanes 2-5) (Fig. 2, lane 2) . In addition, a significant proportion of the protein remained in the unpurified fraction as insoluble inclusion bodies.
Western blot analysis of fusion proteins The identity of the 89 kDa protein as an MBP-ECD fusion protein was confirmed in Western blots using two anti-TSHR peptide antibodies, anti-p59 and anti-p60, each of which revealed a band of 89 kDa for induced E. coli transformed with pMAL-cRl-ECD, but not for non-induced bacteria or control E. coli transformed with pMAL-cRl (Fig. 3a) .
Cleavage of purified MBP-ECD with factor Xa
Extensively dialysed MBP-ECD (1 mg) was cleaved with 40 pg factor Xa and subjected to SDS-PAGE (Fig. 2) (Fig. 3b) expected, some uncleaved material remaining in the sample was recognized by both antisera.
Reactivity of anti-TSHR peptides with purified MBP-ECD
When affinity-purified MBP-ECD protein was coated onto ELISA plates, anti-MBP, anti-p59 and anti-p60 bound with high affinity, but this was not the case with normal rabbit serum or prelS (Fig. 4) ther confirmed using affinity-purified anti-ECD, generated by binding the IS-MBP" on an MBP-ECD-CNBr-Sepharose column and elution at acid pH. two broad bands, at about 95 and 55 kDa, which had the characteristic appearance of glycosylated proteins (Fig. 8a) . These bands were absent in blots of JP02 or in blots of JP09 probed with the prelS or anti-ECD IgGs preincubated with MBP-ECD fusion protein. In contrast, repeated attempts using various human thyroid preparations probed with anti-ECD IgGs revealed only a protein band at about 55 kDa (Fig. 8b) , which was absent from blots probed with the prelS or anti-ECD IgGs preincu¬ bated with MBP-ECD fusion protein.
Immunofluorescence on JP09 and JP02 As shown in Fig. 9 
DISCUSSION
In the present work we describe the production of milligram quantities of a fusion protein containing the ECD of the human TSHR. In previous studies of this type either much lower quantities of protein were produced or (Huang et al. 1992 (Huang et al. , 1993 , where sufficient protein to be visualized by Coomassie blue staining was expressed, it was insoluble and thus impossible to purify from the other bacterial proteins (Harfst et al. 1992 ). We also encountered problems of solubility, as shown by the quantity of protein remaining in the unpurified fraction, but were still able to produce useful quantities of pure material. We can confirm the limited biological activity of the recombinant protein (Huang et al. 1992 (Huang et al. , 1993 (Nagai & Thogersen, 1984 
